LCM
SRPT icon

Landscape Capital Management’s Sarepta Therapeutics SRPT Stock Holding History

Landscape Capital Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-50,298
Closed -$1.09M – 896
2026
Q1 		$1.09M Sell
50,298
-29,373
-37% -$569K 0.07% 367
2025
Q4 		$1.71M Buy
+79,671
New +$1.68M 0.11% 272
2024
Q1 		– Sell
-5,558
Closed -$536K – 967
2023
Q4 		$536K Buy
+5,558
New +$533K 0.05% 393
2017
Q2 		– Sell
-32,162
Closed -$882K – 472
2017
Q1 		$882K Hold
32,162
– – 0.09% 194
2016
Q4 		$882K Buy
+32,162
New +$1.29M 0.12% 178

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Landscape Capital Management's SRPT Position: Q2 2026 in Review

Landscape Capital Management sold out of Sarepta Therapeutics (SRPT) in Q2 2026, closing a stake of 50,298 shares — an estimated $1.09M sold.

Landscape Capital Management first reported a position in SRPT in Q4 2016 and held it in 5 quarters. The position peaked at $1.71M in Q4 2025. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Landscape Capital Management reported no remaining Sarepta Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Landscape Capital Management sold 50,298 Sarepta Therapeutics shares in Q2 2026, an estimated $1.09M.
  • Landscape Capital Management first reported a position in Sarepta Therapeutics in Q4 2016 and held it in 5 quarters.
  • Landscape Capital Management's Sarepta Therapeutics position peaked at $1.71M in Q4 2025.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Landscape Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.